טוען...
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Half a century ago, Harry Angelman reported three patients with overlapping clinical features, now well known as Angelman syndrome. Angelman syndrome is caused by mutations affecting the maternally inherited UBE3A gene, which encodes an E3‐ubiquitin ligase that is critical for typical postnatal brai...
שמור ב:
| הוצא לאור ב: | Dev Med Child Neurol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248324/ https://ncbi.nlm.nih.gov/pubmed/33543479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dmcn.14831 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|